APPARATUS FOR DELIVERING HEMOSTATIC MATERIALS FOR BLOOD VESSEL CLOSURE

(19)

(11)

EP 2 293 724 B8

(12)	CORRECTED EUROPEAN PATENT SPECIFICATION
	Note: Bibliography reflects the latest situation

(15)	Correction information:
	Corrected version no 1 (W1 B1)

(48)	Corrigendum issued on:
	03.01.2018 Bulletin 2018/01

(45)	Mention of the grant of the patent:
	22.11.2017 Bulletin 2017/47

(21)	Application number: 09774368.6

(22)	Date of filing: 30.06.2009

(51)

International Patent Classification (IPC):

A61B 17/08^(2006.01)

(86)	International application number:
	PCT/US2009/049297

(87)	International publication number:
	WO 2010/002918 (07.01.2010 Gazette 2010/01)

(54)	APPARATUS FOR DELIVERING HEMOSTATIC MATERIALS FOR BLOOD VESSEL CLOSURE VORRICHTUNG ZUR FREISETZUNG BLUTSTILLENDER MATERIALIEN FÜR DEN VERSCHLUSS EINES BLUTGEFÄSSES APPAREIL DE MISE EN PLACE DE MATERIAUX HEMOSTATIQUES POUR L'OBTURATION DE VAISSEAUX SANGUINS

(84)	Designated Contracting States:
	AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK TR

(30)

Priority:

30.06.2008 US 77104 P

(43)	Date of publication of application:
	16.03.2011 Bulletin 2011/11

(73)	Proprietor: Cardiva Medical, Inc
	Santa Clara, CA 95054 (US)

(72)	Inventors:
	YASSINZADEH, Zia San Jose CA 95140 (US) PELAYO, Delfin San Jose CA 95123 (US)

(74)	Representative: Kazi, Ilya
	Mathys & Squire LLP The Shard 32 London Bridge Street London SE1 9SG The Shard 32 London Bridge Street London SE1 9SG (GB)

(56)

References cited: :

WO-A1-96/24291
US-A- 5 370 660
US-A1- 2006 100 664
US-A1- 2006 229 670
US-A1- 2007 276 435
US-A1- 2008 071 310

WO-A2-2006/115904
US-A1- 2002 072 768
US-A1- 2006 106 362
US-A1- 2007 212 388
US-A1- 2007 276 435
US-A1- 2008 071 310

Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).